October 23, 2024 at 2:56 pm

Tevogen Bio Soars 50% as Tevogen AI Teams Up with Microsoft for Startups to Accelerate Drug Development

Tevogen Bio (Nasdaq: TVGN), a clinical-stage biotech company developing immunotherapy treatments, announced today that its artificial intelligence division, Tevogen AI, has joined Microsoft’s Startup program. This partnership provides Tevogen access to Microsoft’s cutting-edge AI tools, accelerating the development of proprietary algorithms aimed at reducing the cost and time of drug discovery and development. Tevogen’s leadership… [Read More]
October 23, 2024 at 12:08 pm

Sunrun Partners with Orange and Rockland to Get New York’s Largest Residential Power Plant on the Grid

Sunrun (RUN), the leading provider of clean energy subscription services in the U.S., and Orange and Rockland Utilities, Inc., a subsidiary of Consolidated Edison, Inc. (ED), one of the nation’s largest investor-owned energy companies, have successfully launched New York’s largest residential power plant. This innovative project utilizes over 300 solar-plus-storage systems, which provided stored solar… [Read More]
October 23, 2024 at 11:58 am

Looking Good! OKYO Pharma Doses First Patient in Phase 2 Trial for Corneal Neuropathic Pain, Shares Rise 15%

OKYO Pharma (NASDAQ: OKYO) has announced the dosing of the first patient in its Phase 2 clinical trial of OK-101, a novel, non-opioid treatment for neuropathic corneal pain (NCP), marking a significant milestone in the development of the first drug specifically targeting this condition. NCP, often resulting from eye surgery, infections, or conditions like dry… [Read More]
October 23, 2024 at 10:10 am

PRISM AdTech & Media: Magnite and Disney are Still Making Magic As They Extend Partnership

The largest independent sell-side advertising platform Magnite (MGNI), has announced the extension of its six-year partnership with Disney (DIS) for an additional two years. Maginite has been Disney’s preferred supply-side technology partner, helping Disney monetize its ad-supported inventory across its entire portfolio. Magnite facilitates transactions for over 30 demand-side platforms (DSPs) that collaborate with Disney…. [Read More]
October 23, 2024 at 9:21 am

Starbucks Wakes Up Investors with Q4 Pre-Announcement, Shares Trading Down

Bean brewer Starbucks Corporation (SBUX) woke investors up with a pre-announcement of their Q4 results that have shares trading off in Wednesday pre-market trade. The company’s new CEO Brian Niccol who was formerly CEO for Chipotle Mexican Grill (CMG) stated, “Our Q4 performance makes it clear that we need to fundamentally change our strategy so… [Read More]
October 22, 2024 at 5:19 pm

PRISM Hocus Pocus: Halloween Tricks and Portfolio Treats

We are approaching the first fall holiday which is the unique time of year when you can sip on a pumpkin latte and shop for a Christmas tree while listening to everyone angrily discuss how winter holiday decorations are already on shelves when “it’s not even Halloween yet!!” As if the same thing didn’t happen… [Read More]
October 22, 2024 at 3:38 pm

Athira Pharma to Present Phase 2/3 LIFT-AD Trial Results at CTAD 2024; Shares Up 17%

Athira Pharma, Inc. (Nasdaq: ATHA), a clinical-stage biopharmaceutical company focused on developing treatments for neurodegenerative diseases, announced that it will present the results of its Phase 2/3 LIFT-AD trial of fosgonimeton for Alzheimer’s disease at the Clinical Trials on Alzheimer’s Disease (CTAD) 2024 conference in Madrid. The presentation will take place on October 29, 2024…. [Read More]
October 22, 2024 at 3:14 pm

Annexon Presents Promising Phase 2 Data for ANX007 in Dry AMD at AAO 2024

Annexon, Inc. (Nasdaq: ANNX) presented new findings from its Phase 2 ARCHER study for ANX007 in geographic atrophy (GA) due to dry age-related macular degeneration (AMD) at the American Academy of Ophthalmology (AAO) 2024 meeting. The data demonstrated enhanced protection of vision and greater preservation of central photoreceptor cells in patients with less advanced GA…. [Read More]